Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/21676Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kumar, Ashok | - |
| dc.contributor.author | Sharma, Shalabh | - |
| dc.contributor.author | Bajaj, Kiran | - |
| dc.contributor.author | Bansal, Deepti | - |
| dc.contributor.author | Sharma, Shipra | - |
| dc.contributor.author | Saxena, Archana K K | - |
| dc.contributor.author | Lata, S | - |
| dc.contributor.author | Gupta, B | - |
| dc.contributor.author | Srivastava, V K | - |
| dc.date.accessioned | 2013-10-07T11:15:31Z | - |
| dc.date.available | 2013-10-07T11:15:31Z | - |
| dc.date.issued | 2003-08 | - |
| dc.identifier.issn | 0975-0983(Online); 0376-4699(Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/21676 | - |
| dc.description | 1979-1984 | en_US |
| dc.description.abstract | Synthesis of 2-(ω-chloroacetonyl)-3-substituted-phenyl-6-halo/6,8-dihaloquinazolin-4(3H)-ones 6-10, 2-(ω-hydrazinoacetonyl)-3-substituted-phenyl-6-halo/6,8-dihaloquinazolin-4(3H)ones 11-15 and 1'- [3H-3-substituted-phenyl-4-oxo-6-halo/6,8-dihaloquinazolin-2-acetonyl]-3׳-aryl-5'-(2-substituted-indol-3-yl)-Δ2-pyrazolines 16-30 have been described. All the compounds have been tested in vivo for their anti -inflammatory, analgesic, ulcerogenic activities and acute toxicity. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.rights |  CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | IJC-B Vol.42B(08) [August 2003] | en_US |
| dc.title | Synthesis and anti-inflammatory, analgesic, ulcerogenic and cyclooxygenase activities of novel quinazolinyl-Δ2 -pyrazolines | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJC-B Vol.42B(08) [August 2003] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJCB 42B(8) 1979-1984.pdf | 1.06 MB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.